Announcement of Resolutions of the Fifth Extraordinary Meeting of the Ninth Supervisory Committee of Fosun Pharma in 2024.
Announcement by Fosun Pharma regarding providing guarantees for its holding subsidiaries.
Fosun Pharma's Hong Kong-listed announcement - Securities Change Monthly Report
Announcement of Resolutions of the 51st Meeting (Interim Meeting) of the 9th Board of Directors of Fosun Pharmaceutical
Announcement of Fosun Pharmaceutical on providing guarantees for holding subsidiaries
Fosun Pharmaceutical H Share Announcement
Fosun Pharmaceutical H Share Announcement
Announcement of Fosun Pharmaceutical on providing guarantees for holding subsidiaries
Announcement of Resolutions of the 50th Meeting (Interim Meeting) of the 9th Board of Directors of Fosun Pharmaceutical
Announcement of Resolutions of the 4th Meeting (Interim Meeting) of the 9th Board of Supervisors of Fosun Pharmaceutical in 2024
Fosun Pharmaceutical's Announcement on Holding Results Briefings for the First Quarter of 2023 and 2024
Announcement of Fosun Pharmaceutical on providing guarantees for holding subsidiaries
Fosun Pharmaceutical H Share Announcement-Monthly Statement of Securities Changes
Announcement of Resolutions of the 49th Meeting (Regular Meeting) of the 9th Board of Directors of Fosun Pharmaceutical
Fosun Pharmaceutical's announcement on providing loans and related transactions to joint ventures according to shareholding ratio
Fosun Pharmaceutical H Share Announcement-Board Meeting Date
Announcement of Fosun Pharmaceutical on providing guarantees for holding subsidiaries
Fosun Pharmaceutical Investor Relations Activity Record Form (2024-02)
Fosun Pharmaceuticals: China International Finance Corporation's 2023 Continuous Supervision Site Inspection Report on Shanghai Fosun Pharmaceuticals (Group) Co., Ltd.
Fosun Pharmaceuticals: China International Finance Corporation's 2023 Annual Report on the Continued Supervision of Shanghai Fosun Pharmaceuticals (Group) Co., Ltd.
No Data